JAN 03, 2018 05:01 AM PST

Postpartum Depression is a Disruption in Brain Activity

Postpartum depression (PPD) can be debilitating and severely impact a mother's ability to enjoy her newborn child. The Centers for Disease Control figures show that it affects between 11 and 20% of new mothers, however, those numbers are likely low because so many women do not seek treatment or tell their healthcare providers how they are feeling. If we take the middle of that range, at 15%, that means that close to 600,000 women each year will deal with depression or anxiety after giving birth.

Some normal mood swings are to be expected, but when feeling bad continues beyond a few weeks, women are advised to contact their doctors. True PPD can cause a mother to stop producing milk, feel anxious, sad and even suicidal. Still, roughly 85% of women who experience it report never bringing it to the attention of a medical professional.

A new study from Tufts University in Boston is shedding light on the biological underpinnings of PPD. The work suggests that a neural pathway that regulates stress is involved in what happens to some women after giving. It's even more difficult for moms who have infants that have medical problems, developmental delays or congenital disabilities. PPD is seen in much higher numbers with mothers who have these additional stress issues.

The research investigated a stress pathway called the hypothalamic-pituitary-adrenal (HPA) axis. It's this pathway of neurons that can trigger a fight or flight response. In pregnancy, the brain tamps down on this reaction, because stress is detrimental to a developing baby and it's the body's way of protecting the fetus. This response and the pathway in the brain that it follows are driving by a hormone called corticotropin-releasing hormone (CRH), which is secreted when the body is stressed. CVH and the HPA axis have all been indicated in research looking at the causes of PPD, but the connection wasn't complete until the Tufts research. PPD is much more likely to occur when the HPA axis is disrupted.

Neuroscientist Jamie Maguire from Tufts University explained, "Some clinical studies show a relationship between CRH, HPA axis function and postpartum depression, but others fail to replicate these findings. Direct investigation into this relationship has been hindered due to the lack of useful animal models of such a complex disorder. Using a mouse model that we developed, our new study provides the first empirical evidence supporting the clinical observations of HPA axis dysfunction in patients with postpartum depression and shows for the first time that dysregulation of the HPA axis and a specific protein in the brain, KCC2, can be enough to induce postpartum depression-like behaviors and deficits in maternal care."

KCCR is a protein in the brain that regulates how much CRH is released by the brain. Mice that had never been bred or given birth were exposed to stress, and KCCR was suppressed, which left levels of CRH unregulated. When mice who were pregnant or newly postpartum stressed, KCCR was abundant and limited the CRH response. In the study, a specific mouse was developed that was genetically altered to completely lack the KCCR protein. During the pregnancies and post-partum period of these "knockout" mice, depressive behaviors were seen. The mice who lacked KCCR were more reluctant to care for their pups, exhibited more stress and anxiety during pregnancy, and this stress did not abate after giving birth. When the researchers were able to silence the brain cells that secreted CRH, the mice were less stressed and better caretakers of their pups.

While the study was a mouse model and may not translate to human mothers, understanding the specific pathways of stress hormones in pregnancy is a significant first step in finding treatment for the thousands of women who suffer from PPD. The team at Tufts hopes to move forward with their research to develop a biomarker that could identify women most at risk. The video below explains more about the study, take a look.

Sources: Tufts University, Psychoneuroendocrinology, Mummypages

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
NOV 10, 2018
Health & Medicine
NOV 10, 2018
Heart Attack Or Panic Attack? Knowing When To Seek Help
Chest pain, shortness of breath, and feelings of impending doom are all symptoms representative of both heart attacks and panic attacks. For this reason, i...
DEC 12, 2018
Health & Medicine
DEC 12, 2018
Let it All Out - Swearing is Healthy for You
Lalochezia is an emotional relief obtained by spewing vulgar language, and science suggests that swearing regularly could be good for your overall health a...
DEC 17, 2018
Health & Medicine
DEC 17, 2018
A Migraine Associated Specific Mutation Increases Neuronal Excitability
One subtype of K2P channel expressed in sensory neurons, TRESK has been reported to play a role in MA in its truncated from TRESK-MT....
JAN 01, 2019
Health & Medicine
JAN 01, 2019
Growing Old With Autism
  While ASD spectrum disorder (ASD) is a major disability many people are aware of, the term was practically unheard of half a century ago, fewer chil...
JAN 07, 2019
Neuroscience
JAN 07, 2019
Anti-Epileptic Stem Cells
Researchers from the Texas A&M College of Medicine, demonstrated that grafting of medial ganglionic eminence (MGE)-derived GABA-ergic progenitor cells into the hippocampus subdued the seizure...
JAN 19, 2019
Microbiology
JAN 19, 2019
Gut Bacteria Influence the Efficacy of a Parkinson's Drug
A type of bacteria in the gut make an enzyme that can interfere with levodopa, a Parkinson's disease therapy....
Loading Comments...